Dutkiewicz, Slawomir A <br/><br/>
Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1.  [electronic resource] 

 -  International urology and nephrology  Apr 2012 
 - 487-92 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1573-2584 
<br/><br/><label>Standard No.: </label>10.1007/s11255-011-0051-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--administration & dosage<br/>Biopsy<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Endosonography<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prospective Studies<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Time Factors<br/>Treatment Outcome